Mirikizumab (Anti-IL-23)
Mirikizumab (Anti-IL-23) is a humanized IgG4 monoclonal antibody that targets the p19 subunit of interleukin 23. Mirikizumab can be used for research on ulcerative colitis. MW: 144.26 KD.
| Trivial name | LY3074828 |
| Catalog Number | A2967 |
| CAS# | 1884201-71-1 |
| Size | 1mg*25 |